Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin in Pediatric Invasive Candidiasis
NCT00761267Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Feb 2018
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 10
01
Overview
A Phase 3 trial of anidulafungin in invasive candidiasis, sponsored by Pfizer. Started Feb 2009; status: completed.
02
Drugs
anidulafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT00761267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761267.